Back to search

Article

Adebrelimab plus apatinib and SOX (AASOX) as conversion therapy for borderline resectable gastric cancer: a single-arm, single-centre, exploratory phase II study

2026-07-25

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Borderline resectable gastric cancer—clinical T4b disease with bulky locoregional lymphadenopathy, oligometastatic liver involvement, or both—remains a major therapeutic challenge because upfront curative resection is often infeasible. We evaluated the efficacy and safety of adebrelimab (anti–PD-L1) plus apatinib (anti–VEGFR-2) and SOX (AASOX) as conversion th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a41c131e-30fe-5570-8ec7-7b511a14a3c4
DOI
10.21203/rs.3.rs-10176838/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adebrelimab plus apatinib and SOX (AASOX) as conversion therapy for borderline resectable gastric cancer: a single-arm, single-centre, exploratory phase II studyDOI 10.21203/rs.3.rs-10176838/v1
Sintilimab plus irinotecan, leucovorin and 5-fluorouracil (FOLFIRI) as salvage treatment for patients with advanced gastric cancer: real-world evidence from a single-centre cohortSemantic proximity
Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studySemantic proximity
Gemcitabine plus Oxaliplatin (GEMOX) combined with Atezolizumab and Bevacizumab for Advanced Biliary Tract Cancer: A Preliminary Observational StudySemantic proximity
[Advanced GIST: Which treatments in 2022?]Semantic proximity
The Efficacy and Safety of Sacituzumab Govitecan in Heavily Pretreated Metastatic Triple-Negative and Hormone Receptor-Positive/HER2-Negative Breast Cancer: A Multicenter Real-World Study from TurkeySemantic proximity
Presurgical ablative radiation associates with local control and immune response in pancreatic cancerSemantic proximity
Application of combined multiple organ resection in the treatment of locally advanced gastric cancerSemantic proximity
Chemotherapy and targeted therapy for advanced biliary tract cancers：An umbrella reviewSemantic proximity
Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world studySemantic proximity
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONOSemantic proximity
Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)Semantic proximity
Intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial (METAPANC)Semantic proximity
Select a neighboring publication to make it the new centre.